Oncopeptides Cash from Financing (TTM) Analysis

Oncopeptides AB (ONPPF)

0.265 0.00 (0.00%) USD | OTCM | May 06, 16:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
September 30, 2023	11.82M
June 30, 2023	50.88M
March 31, 2023	39.38M
December 31, 2022	39.12M
September 30, 2022	38.35M
June 30, 2022	-3.61M
March 31, 2022	119.97M
December 31, 2021	120.81M
September 30, 2021	115.67M
June 30, 2021	201.03M
March 31, 2021	145.38M
December 31, 2020	144.56M

Date	Value
September 30, 2020	154.92M
June 30, 2020	143.68M
March 31, 2020	74.37M
December 31, 2019	130.88M
September 30, 2019	126.11M
June 30, 2019	55.37M
March 31, 2019	54.83M
December 31, 2018	35.13M
September 30, 2018	30.43M
June 30, 2018	36.49M
March 31, 2018	39.78M
December 31, 2017	74.72M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-3.61M

Minimum

Jun 2022

201.03M

Maximum

Jun 2021

94.93M

Average

117.82M

Median

Cash from Financing (TTM) Benchmarks